טוען...
Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double‐blind, placebo‐controlled trials in adults with binge‐eating disorder
OBJECTIVE: This study examined the time course of efficacy‐related endpoints for lisdexamfetamine dimesylate (LDX) versus placebo in adults with protocol‐defined moderate to severe binge‐eating disorder (BED). METHODS: In two 12‐week, double‐blind, placebo‐controlled studies, adults meeting DSM‐IV‐T...
שמור ב:
| הוצא לאור ב: | Int J Eat Disord |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5573905/ https://ncbi.nlm.nih.gov/pubmed/28481434 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/eat.22722 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|